Autopsy Biosafety

Abstract

Introduction:

As invasive meningococcal disease progresses rapidly, often affects youth, and has a fairly high mortality rate, such cases are likely to fall under medical examiner/coroner (ME/C) jurisdiction. Morgue personnel may be at risk of contracting secondary meningococcal disease. We review the current scientific literature regarding Neisseria meningitidis infection and provide recommendations for the prevention of meningococcal disease at autopsy.

Methods:

A PubMed search utilizing applicable medical subject heading terms was performed retrieving articles for review from the preceding two decades. Pertinent current guidelines from multiple national organizations were also retrieved.

Results:

Invasive meningococcal disease is transmitted by direct contact with large respiratory droplets or oral secretions. While a surgical mask would normally provide adequate protection from large droplet spread, it does not prevent inhalation of smaller aerosolized particles such as those generated at autopsy. Prosectors are advised to routinely wear N-95 respirator masks or powered respirator hoods. All published cases of secondary meningococcal disease transmission to healthcare workers invariably arose in scenarios in which face masks/respirators were not employed; none of these cases involved meningococcal disease transmission to ME/C or other morgue staff.

Discussion:

In the event that no mask—or inadequate coverage such as a surgical mask—is employed during autopsy of a decedent suspected/confirmed to have invasive meningococcal disease, antibiotic prophylaxis is advisable. Assuming appropriate personal protective equipment is utilized, chemoprophylaxis is unnecessary. Routine meningococcal vaccination is not recommended, except for ME/C with specified immunocompromising conditions or traveling to hyperendemic/endemic meningococcal regions. Acad Forensic Pathol. 2018 8(2): 328-339

Keywords

Forensic pathology Autopsy Biosafety Biohazards Meningococcus Meningitis

Get full access to this article

View all access options for this article.

References

Van Deuren

Brandtzaeg

van der Meer

. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev. 2000; 13(1):144–66. PMID: 10627495. PMCID: PMC88937. https://doi.org/10.1128/cmr.13.1.144-166.2000.

Gardner

. Prevention of meningococcal disease. N Engl J Med. 2006 10 5; 355(14):1466–73. PMID: 17021322. https://doi.org/10.1056/nejmcp063561.

Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington: Public Health Foundation, c2015. Chapter 14, Meningococcal disease; p.231–46.

Christensen

May

Bowen

. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010 12; 10(12):853–61. PMID: 21075057. https://doi.org/10.1016/S1473-3099(10)70251-6.

Cohn

MacNeil

Clark

. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 3 22; 62(RR-2):1–28. PMID: 23515099 https://doi.org/10.1037/e548762006-001.

Enhanced meningococcal disease surveillance report, 2015 [Internet]. Atlanta: Centers for Disease Control and Prevention; 2017 9 [cited 2018 Jan 7]. 2 p. Available from: https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2015.pdf.

Enhanced meningococcal disease surveillance report, 2016 [Internet]. Atlanta: Centers for Disease Control and Prevention; 2017 9 [cited 2018 Jan 7]. 2 p. Available from: https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf.

Centers for Disease Control and Prevention [Internet]. Atlanta: US Department of Health & Human Services; c2018. Meningococcal disease: surveillance; [cited 2018 Jan 7]. Available from: https://www.cdc.gov/meningococcal/surveillance/index.html.

Folaranmi

Rubin

Martin

. Use of serogroup B meningococcal vaccines in persons aged ≥10 Years at increased risk for serogroup B meningococcal disease: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep. 2015 6 12; 64(22); 608–12. PMID: 26068564. PMCID: PMC4584923.

10.

United States Food and Drug Administration [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services; c2018. Drugs@FDA: FDA Approved Drug Products. Alexion Pharmaceuticals Supplemental Approval-422; [cited 2018 Jan 7]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166.

11.

MacNeil

Rubin

Patton

. Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons — advisory committee on immunization practices, 2016. MMWR Morb Mortal Wkly Rep. 2016 11 4; 65(43):1189–1194. PMID: 27811836. https://doi.org/10.15585/mmwr.mm6543a3.

12.

Boutet

Stuart

Kaczmarski

. Risk of laboratoryacquired meningococcal disease. J Hosp Infect. 2001 12; 49(4): 282–4. PMID: 11740877. https://doi.org/10.1053/jhin.2001.1084.

13.

Boutet

Stuart

Jones

Kaczmarski

. Prevention of meningococcal infection in laboratory workers--an audit of practice in England and Wales. Commun Dis Public Health. 2001 6; 4(2):130–2. PMID: 11525001.

14.

Sejvar

Johnson

Popovic

. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol. 2005 9; 43(9):4811–14. PMID: 16145146. PMCID: PMC1234112. https://doi.org/10.1128/JCM.43.9.4811-4814.2005.

15.

Singh

. Laboratory-acquired infections. Clin Infect Dis. 2009 7 1; 49(1):142–7. PMID: 19480580. https://doi.org/10.1086/599104.

16.

Baron

Miller

. Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks. Diagn Microbiol Infect Dis. 2008 3; 60(3):241–6. PMID: 17997259. https://doi.org/10.1016/j.diagmicrobio.2007.09.016.

17.

Kessler

Stephens

Somani

. Laboratory-acquired serogroup A meningococcal meningitis. J Occup Health. 2007 9; 49(5): 399–401. PMID: 17951972. https://doi.org/10.1539/joh.49.399.

18.

Athlin

Vikerfors

Fredlund

Olcén

. Atypical clinical presentation of laboratory-acquired meningococcal disease. Scand J Infect Dis. 2007; 39(10):911–3. PMID: 17852886. https://doi.org/10.1080/00365540701367827.

19.

Omer

Rose

Jolley

. Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage. PLoS One. 2011 2 28; 6(2): e17145. PMID: 21386889. PCMID: PMC3046118. https://doi.org/10.1371/journal.pone.0017145.

20.

Weber

Rutala

. Occupational health update: focus on preventing the acquisition of infections with pre-exposure prophylaxis and postexposure prophylaxis. Infect Dis Clin North Am. 2016 9; 30(3):729–57. PMID: 27515145. https://doi.org/10.1016/j.idc.2016.04.008.

21.

Centers for Disease Control and Prevention (CDC). Occupational transmission of Neisseria meningitidis --- California, 2009. MMWR Morb Mortal Wkly Rep. 2010 11 19; 59(45):1480–3. PMID: 21085089.

22.

Gehanno

Kohen-Couderc

Lemeland

Leroy

. Nosocomial meningococcemia in a physician. Infect Control Hosp Epidemiol. 1999 8; 20(8):564–5. PMID: 10466560. https://doi.org/10.1086/501672.

23.

Gilmore

Stuart

Andrews

. Risk of secondary meningococcal disease in health-care workers. Lancet. 2000 11 11; 356(9242): 1654–5. PMID: 11089828. https://doi.org/10.1016/S0140-6736(00)03163-9.

24.

Petsas

Sharma

Aghadiuno

. A secondary case of meningococcal disease in an ambulance worker, Berkshire, November 2007. Euro Surveill. 2008 1 24; 13(4). pii: 8020. PMID: 18445400.

25.

Fusco

Puro

. Meningococcal disease in an ambulance worker. Euro Surveill. 2008 3 6; 13(10). pii: 8061. PMID: 18445438. https://doi.org/10.2807/ese.13.10.08061-en.

26.

Riccò

Vezzosi

Odone

Signorelli

. Invasive meningococcal disease on the workplaces: a systematic review. Acta Biomed. 2017 10 23; 88(3):337–351. PMID: 29083344.

27.

Heckenberg

de Gans

Brouwer

. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008 7; 87(4):185–92. PMID: 18626301. https://doi.org/10.1097/MD.0b013e318180a6b4.

28.

Aurelius

MB.

Autopsy Performance and Reporting. 3 rd ed. Northfield, IL: College of American Pathologists; c2017. Chapter 12, Autopsy safety; p. 81–90.

29.

Nine

JS.

Autopsy performance and reporting. 3 rd ed. Northfield (IL): College of American Pathologists; c2017. Chapter 13, High-risk autopsy cases; p. 91–8.

30.

Nolte

Taylor

Richmond

. Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002 6; 23(2):107–22. PMID: 12040252. https://doi.org/10.1097/00000433-200206000-00001.

31.

Nolte

Hanzlik

Payne

Kroger

. Medical examiners, coroners, and biologic terrorism: a guidebook for surveillance and case management. MMWR Recomm Rep. 2004 6 11; 53(RR-8):1–27. PMID: 15192550. https://doi.org/10.1037/e548602006-001.

32.

Nolte

Guarner

Shieh

Zaki

. Handbook of forensic pathology. 2nd ed. Northfield (IL): College of American Pathologists; c2003. Chapter 36, Emerging infectious diseases and the medical examiner; p. 345–60.

33.

Hospital respiratory protection program toolkit: resources for respirator program administrators [Internet]. Washington: Occupational Safety and Health Administration; 2015 5 [cited 2018 Jan 8]. 32 p. Available from: https://www.osha.gov/Publications/OSHA3767.pdf.

34.

Wenner

Pauli

Summermatter

. Aerosol generation during bone-sawing procedures in veterinary autopsies. Vet Pathol. 2017 5; 54(3):425–436. PMID: 28113035. https://doi.org/10.1177/0300985816688744.

35.

Lindsley

Noti

Blachere

. Efficacy of face shields against cough aerosol droplets from a cough simulator. J Occup Environ Hyg. 2014; 11(8):509–18. PMID: 24467190. PMCID: PMC4734356. https://doi.org/10.1080/15459624.2013.877591.

36.

Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC). Immunization of health-care personnel: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2011 11 25; 60(RR-7):1–45. PMID: 22108587.

37.

Pollard

Begg

. Meningococcal disease and healthcare workers. BMJ. 1999 10 30; 319(7218):1147–8. PMID: 10541486. PMCID: PMC1116940. https://doi.org/10.1136/bmj.319.7218.1147.

38.

Stuart

Gilmore

Ross

. Preventing secondary meningococcal disease in health care workers: recommendations of a working group of the PHLS meningococcus forum. Commun Dis Public Health. 2001 6; 4(2):102–5. PMID: 11524996.

39.

Graham

Dreimanis

. Chemoprophylaxis. Collegian. 1998 4; 5(2):9. PMID: 9644332.

40.

Marks

Neal

. Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners. BMC Public Health. 2001; 1:16. PMID: 11806758. PMCID: PMC64787. https://doi.org/10.1186/1471-2458-1-16.

41.

Giovanetti

. Anaphylaxis following unnecessary meningococcal chemoprophylaxis of a healthcare worker. Euro Surveill. 2009 5 14; 14(19). pii: 19207. PMID: 19442400. https://doi.org/10.2807/ese.14.19.19207-en.

42.

Cowling

Meningococcal disease in healthcare workers. Prophylaxis is not necessary. BMJ. 2000 1 22; 320(7229):247; author reply 248-9. PMID: 10712018.

43.

Galloway

Fulton

Flood

. Meningococcal disease in healthcare workers. Long term effects and costs are unclear. BMJ. 2000 1 22; 320(7229):248; author reply 248-9. PMID: 10712020.

44.

Gilmore

Stuart

Cartwright

Patterson

. Meningococcal disease in healthcare workers. Recommendation will cause unease among healthcare staff. BMJ. 2000 1 22; 320(7229):247–8; author reply 248-9. PMID: 10712019.

45.

Wilcox

Modi

. Meningococcal disease in healthcare workers. Ceftriaxone may be helpful. BMJ. 2000 1 22; 320(7229):248–9. PMID: 10712021.

46.

Bazan

Mangino

. Infection control and postexposure prophylaxis for the pregnant healthcare worker. Clin Obstet Gynecol. 2012 6; 55(2):571–88. PMID: 22510640. https://doi.org/10.1097/grf.0b013e31824f3a07.